Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 2 completed trials

    Completion Rate
    100%(2/2)
    Active Trials
    0(0%)
    Results Posted
    0%(0 trials)

    Phase Distribution

    Phase 2
    1
    33%
    Not Applicable
    2
    67%

    Phase Distribution

    0

    Early Stage

    1

    Mid Stage

    0

    Late Stage

    Phase Distribution3 total trials
    Phase 2Efficacy & side effects
    1(33.3%)
    N/ANon-phased studies
    2(66.7%)

    Highest Phase Reached

    Phase 2

    Trial Status & Enrollment

    Completion Rate

    100.0%

    2 of 2 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    3

    all time

    Status Distribution
    Completed(2)
    Other(1)

    Detailed Status

    Completed2
    unknown1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    3
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    Phase 2

    Trials by Phase

    Phase 21 (33.3%)
    N/A2 (66.7%)

    Trials by Status

    unknown133%
    completed267%

    Recent Activity

    0 active trials
    Showing 3 of 3
    unknownphase_2

    Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Advanced Epithelial Ovarian Carcinomas

    NCT02033616
    completednot_applicable

    Two Surgical Approaches for Root Coverage of Teeth Presenting Gingival Recession and Non-carious Cervical Lesion

    NCT03341598
    completednot_applicable

    Evaluation of Two Types of Matrix (Mucograft® and Mucoderm®) Associated With Coronally Advanced Flap

    NCT03667105

    Clinical Trials (3)

    Showing 3 of 3 trials
    NCT02033616Phase 2

    Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Advanced Epithelial Ovarian Carcinomas

    Unknown
    NCT03341598Not Applicable

    Two Surgical Approaches for Root Coverage of Teeth Presenting Gingival Recession and Non-carious Cervical Lesion

    Completed
    NCT03667105Not Applicable

    Evaluation of Two Types of Matrix (Mucograft® and Mucoderm®) Associated With Coronally Advanced Flap

    Completed

    All 3 trials loaded

    Drug Details

    Intervention Type
    Varies by study
    Total Trials
    3